3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is increasingly attracting clinical scrutiny due to sparse evidence suggesting distinct biological characteristics. Preliminary analyses demonstrate https://www.pinterest.com/pin/1140888518124046392/